Bharat Immunologicals Price to Sales

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 21.3  0.1  0.47%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bharat Immunologicals 
P/S 
 = 
MV Per Share 
Revenue Per Share 
 = 
0.66 times

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition
Based on latest financial disclosure the price to sales indicator of Bharat Immunologicals Biologicals Corp Ltd is roughly 0.66 times. This is much higher than that of the sector, and significantly higher than that of Price to Sales industry, The Price to Sales for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Price to Sales Comparison
Bharat Immunologicals is currently under evaluation in price to sales category among related companies.

Did you try this?

Run Crypto Portfolio Optimizer Now
   

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
Hide  View All  NextLaunch Crypto Portfolio Optimizer

Fundamental Indicators

Current Bharat Immunologicals financial ratios